Antiseizure medication outcome was examined in drug-resistant epilepsy patients using claims data Most patients were drug experienced at baseline, over 1/3 of patients persisted on their first-drug regimen at 1 year posttreatment 49% of patients who failed the first regimen failed their second regimen and were then considered as drug resistant Comorbidities increased the risk of failure while older age and male gender lowered the risk Mental illnesses present in over 1/3 of the study cohort...
Steve Arcona
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Steve
Contact Steve, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack